Concord Biotech Ltd Stock News
Concord Biotech Ltd Share Price
Detail Overview₹1,229.30
-41.40(-3.26%)
As on 23 Oct 2026 at 15:54
As of 23 Oct 2026 at 15:54, Concord Biotech Ltd is trading at ₹1,229.30. The 52-week range stands at ₹987.00–₹1,615.00, with a market cap of ₹12.86 thousand crore. At a P/E of 45.21 and a dividend yield of 0.61%, it is a mid-cap stock in the Pharmaceuticals sector.
CONCORDBIO Price Chart
Market Cap
₹12.86K Cr
PE Ratio
45.21
ROCE
17.41%
Concord Biotech Ltd Latest News
View More22 OCT 2026 | Thursday
Concord Biotech to review Q2 financial results at board meeting on October 27, 2026
07 OCT 2026 | Wednesday
Concord Biotech confirmed securities handling compliance with a certificate filed with Indian exchanges
28 SEPT 2026 | Monday
Concord Biotech halts share trading October 1st pending financial results declaration
19 SEPT 2026 | Saturday
Concord Biotech to consider bonus equity shares at board meeting on September 23, 2026
29 JUL 2026 | Wednesday
Concord Biotech to discuss results
08 JUL 2026 | Wednesday
Concord Biotech schedules AGM
25 JUN 2026 | Thursday
Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
25 JUN 2026 | Thursday
Concord Biotech's formulation facility clears regulatory inspections by Kenya's PPB & Uganda's NDA
12 JUN 2026 | Friday
Concord Biotech completes ANVISA inspection at Limbasi API facility
12 JUN 2026 | Friday
Concord Biotech's Limbasi unit clears Brazilian health regulatory inspection
